CG
CLB icon

Colony Group’s Core Laboratories CLB Stock Holding History

Colony Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20,480
Closed -$1.07M – 701
2019
Q2 		$1.07M Sell
20,480
-1,021
-5% -$59.9K 0.03% 374
2019
Q1 		$1.48M Buy
21,501
+6,513
+43% +$437K 0.06% 244
2018
Q4 		$894K Sell
14,988
-18,066
-55% -$1.56M 0.04% 273
2018
Q3 		$3.83M Sell
33,054
-173
-0.5% -$19.5K 0.19% 111
2018
Q2 		$4.19M Sell
33,227
-3,136
-9% -$382K 0.22% 113
2018
Q1 		$3.94M Buy
36,363
+1,721
+5% +$190K 0.21% 110
2017
Q4 		$3.79M Sell
34,642
-2,548
-7% -$254K 0.24% 93
2017
Q3 		$3.67M Buy
37,190
+3,183
+9% +$309K 0.25% 87
2017
Q2 		$3.44M Buy
34,007
+1,386
+4% +$149K 0.25% 89
2017
Q1 		$3.77M Sell
32,621
-635
-2% -$73.8K 0.36% 67
2016
Q4 		$3.99M Buy
33,256
+700
+2% +$77.5K 0.43% 60
2016
Q3 		$3.66M Buy
32,556
+282
+0.9% +$32.5K 0.41% 57
2016
Q2 		$4M Sell
32,274
-101
-0.3% -$12.2K 0.44% 57
2016
Q1 		$3.64M Buy
32,375
+12,907
+66% +$1.34M 0.42% 58
2015
Q4 		$2.12M Sell
19,468
-70
-0.4% -$8.01K 0.19% 125
2015
Q3 		$1.95M Buy
19,538
+237
+1% +$25.8K 0.23% 102
2015
Q2 		$2.2M Buy
19,301
+255
+1% +$30.9K 0.23% 95
2015
Q1 		$1.99M Buy
19,046
+2,442
+15% +$260K 0.22% 103
2014
Q4 		$2M Sell
16,604
-832
-5% -$109K 0.21% 111
2014
Q3 		$2.55M Buy
17,436
+72
+0.4% +$11.1K 0.29% 79
2014
Q2 		$2.9M Sell
17,364
-225
-1% -$40K 0.39% 60
2014
Q1 		$3.49M Buy
17,589
+469
+3% +$88.5K 0.47% 58
2013
Q4 		$3.27M Sell
17,120
-815
-5% -$152K 0.46% 58
2013
Q3 		$3.03M Sell
17,935
-1,835
-9% -$285K 0.6% 48
2013
Q2 		$3M Buy
+19,770
New +$2.8M 0.6% 45

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Colony Group's CLB Position: Q3 2019 in Review

Colony Group sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 20,480 shares — an estimated $1.07M sold.

Colony Group first reported a position in CLB in Q2 2013 and held it in 25 quarters. The position peaked at $4.19M in Q2 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • Colony Group reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
  • Colony Group sold 20,480 Core Laboratories shares in Q3 2019, an estimated $1.07M.
  • Colony Group first reported a position in Core Laboratories in Q2 2013 and held it in 25 quarters.
  • Colony Group's Core Laboratories position peaked at $4.19M in Q2 2018.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Colony Group's 13F filing for Q3 2019, filed 26 Nov 2019.